The Koch Institute for Integrative Cancer Research at MIT

Mosaic of colored tiles and images of research and people

Celebrating 50 years of collaboration, innovation, and curiosity in cancer research at MIT

Our Research Areas

From fundamental discoveries to engineering advances, we strategically pursue five areas of research that, across tumor types, are critical for rapid progress toward defeating cancer.

As a National Cancer Institute-designated basic cancer research center, we produce knowledge and tools to fight one of humanity's most persistent challenges.

NCI Cancer Center: A Cancer Center Designated by the National Cancer Institute

News

Matthew Vander Heiden elected to National Academy of Medicine
 

MIT News

Congratulations to Koch Institute Director Matthew Vander Heiden, for his election to the National Academy of Medicine! Professor Vander Heiden and his fellow 2024 inductees are being honored for their outstanding professional achievement and commitment to service.

Recognized for his research on cancer metabolism, Vander Heiden—who is also a practicing oncologist—has uncovered critical insights into how cancer cells fuel their growth, leading to innovative therapies for cancer and other diseases. His work continues to shape cancer treatment strategies, making a profound impact on the future of medicine. This honor highlights his dedication to advancing health and science.

At the Koch Institute for Integrative Cancer Research, scientists and engineers work together to solve some of the most difficult problems in cancer. We ask big questions in strategic areas, where the answers have big impacts on how we understand and treat cancer.